Boston Scientific Corporation vs Lufax Holding Ltd — how do they compare? Boston Scientific Corporation trades at $42.65 (market cap $66.37B), while Lufax Holding Ltd trades at $1.31 (market cap $2.41B). The key difference: Boston Scientific Corporation is far larger — about 27.5× Lufax Holding Ltd's market cap. Which is the better fit depends on your goals.
| BSX | LU | |
|---|---|---|
Market Cap | $66.37B | $2.41B |
Sector | Health | Technology |
52-Week High | $108.14 | $4.40 |
52-Week Low | $42.63 | $1.23 |
Enterprise Value | $75.94B | — |
Trailing returns across standard periods
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →Lufax Holding Ltd is a leading financial technology (fintech) platform in China. The company operates a technology-driven personal financial services platform that offers a wide range of loans and wealth management products to its users. Lufax primarily serves the rapidly growing wealth and consumption needs of China’s mass affluent and affluent populations through a combination of its digital platform and an extensive offline network.
Read more on LU →